1. Efficacy and safety of duloxetine in Chinese patients with chronic pain due to osteoarthritis: a randomized, double-blind, placebo-controlled study 
G. Wang, L. Bi, X. Li, Z. Li, D. Zhao, J. Chen, D. He, C.-N. Wang, H. Dueñas, V. Skljarevski, L. Yue 
Osteoarthritis and Cartilage 
Volume 25, Issue 6, Pages (June 2017)
DOI: /j.joca
Copyright © 2017 Osteoarthritis Research Society International Terms and Conditions

2. Fig. 1 Patient disposition.
Osteoarthritis and Cartilage  , DOI: ( /j.joca )
Copyright © 2017 Osteoarthritis Research Society International Terms and Conditions

3. Fig. 2
Change in mean of 24-h BPI Average Pain severity. Abbreviations: N = number of randomized patients with nonmissing data at week 1 postbaseline.
Osteoarthritis and Cartilage  , DOI: ( /j.joca )
Copyright © 2017 Osteoarthritis Research Society International Terms and Conditions

4. Fig. 3
Response to treatment* and proportions of patient responses to treatment on the PGI-Improvement Scale. *Note: Response to treatment was defined as endpoint PGI-Improvement rating of either ‘much better’ or ‘very much better’. aP-value assesses placebo vs duloxetine for response categories overall (a Fisher exact test). Abbreviation: N = Number of randomized patients with nonmissing data at baseline and endpoint.
Osteoarthritis and Cartilage  , DOI: ( /j.joca )
Copyright © 2017 Osteoarthritis Research Society International Terms and Conditions